Abstract
Antibody secretion is executed by plasma cells that are generated in the periphery and migrate to the bone marrow to establish a long lived pool. The terminal differentiation of B lymphocytes into plasma cells is executed by a network of transcription factors that cross-regulate each other in order to irreversibly promote this transition. While major progress has been made in the understanding the transcriptional activity of the underlying master regulators, much less is known on the metabolic regulation of plasma cell differentiation that is required to support antibody synthesis, folding and secretion at high levels and allow their long-lasting survival. In this review we will address the known cross talks between the transcription and metabolic control of plasma cells and elaborate on the gaps of knowledge in the field.
| Original language | American English |
|---|---|
| Pages (from-to) | 12-17 |
| Number of pages | 6 |
| Journal | Journal of Clinical Immunology |
| Volume | 36 |
| DOIs | |
| State | Published - 1 May 2016 |
Bibliographical note
Funding Information:Research was funded by grants from David R. Bloom center for pharmacy, and the Dr. Adolph and Klara Brettler Center for Research in Pharmacology, the Rosetrees Trust, Israeli Cancer Association, Israeli Multiple Myeloma Fund, the Israel Science Foundation (grant 696/14) and the Fritz Thyssen foundation.
Publisher Copyright:
© 2016, Springer Science+Business Media New York.
Keywords
- ER stress
- RIDD
- TSC
- UPR
- mTOR
- oxidative stress
- plasma cells